Home > Insider Trading > Filing (0000200406-11-000115)

Filing Details

Accession Number:: 0000200406-11-000115
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-11-04 16:53:59
Reporting Period:: 2011-11-03

Filing Date:: 2011-11-04
Accepted Time:: 2011-11-04 16:53:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189000	C Russell Deyo	Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933	Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-03	123,300	$57.30	272,080	No	4	M	Direct
Common Stock	Disposition	2011-11-03	123,300	$64.09	148,780	No	4	S	Direct
Common Stock	Acquisiton	2011-10-31	317	$0.00	7,156	No	5	J	Indirect	Johnson & Johnson Stock Fund under the 401(k) Savings Plan
Common Stock	Acquisiton	2011-06-16	594	$0.00	2,634	No	5	G	Indirect	By Daughter
Common Stock	Acquisiton	2011-06-16	594	$0.00	3,333	No	5	G	Indirect	By Son
Common Stock	Disposition	2011-06-16	1,188	$0.00	0	No	5	G	Indirect	By GRAT

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	5	J	Indirect	Johnson & Johnson Stock Fund under the 401(k) Savings Plan
No	5	G	Indirect	By Daughter
No	5	G	Indirect	By Son
No	5	G	Indirect	By GRAT

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-11-03	123,300	$0.00	123,300	$57.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-02-12	2012-02-10	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,703	Indirect	ESOP under the 401(k) Savings Plan
Common Stock	10,771	Indirect	By Wife

Footnotes

Adjusted to reflect: 03/10/2011 addition of 2,551 shares formerly held by GRAT; and 06/16/11 addition of 973 shares formerly held by GRAT.
On May 26, 2004, the reporting person contributed shares of common stock to a grantor retained annuity trust for the benefit of himself and his children. Upon termination of the trust, on June 16, 2011, 594 shares were transferred to each of the reporting person's children. The remaining 973 shares were distributed to the reporting person and continue to be reported in this Form 4 as directly owned.
This transaction was executed in multiple trades at prices ranging from $64.00 to $64.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares acquired in the Johnson & Johnson Stock Fund under the 401(k) Savings Plan as of Plan's most recent reporting date (10/31/2011).
Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (10/31/2011).
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.